Vireo Health Provides Corporate Governance Update
On October 5, 2020, Vireo Health International (CNSX: VREO, OTCQX: VREOF) announced the resignation of Ari Hoffnung from its Board of Directors and as Chief Strategy Officer. Vireo's Chairman and CEO, Kyle Kingsley, praised Hoffnung's five years of leadership that significantly contributed to the company's growth as a multi-state operator in the U.S. Vireo Health focuses on the medical cannabis market, operating in seven states and Puerto Rico, with a commitment to technological and scientific advancements in cannabis production.
- Ari Hoffnung's leadership contributed to Vireo's growth as a multi-state operator.
- Vireo operates in seven states and Puerto Rico, enhancing its market presence.
- The resignation of the Chief Strategy Officer may signal organizational instability.
MINNEAPOLIS, Oct. 5, 2020 /PRNewswire/ -- Vireo Health International, Inc. ("Vireo" or the "Company") (CNSX: VREO, OTCQX: VREOF), the science-focused, multi-state cannabis company with active operations in exclusively medical-only markets and licenses in seven states and the Commonwealth of Puerto Rico, today announced that Ari Hoffnung has resigned from the Board of Directors and his role as Chief Strategy Officer, effective October 5th.
"We are deeply grateful for Ari's five years of extraordinary contributions as a Board Member and Officer of Vireo," said Chairman & Chief Executive Officer, Kyle Kingsley, M.D. "Ari's leadership was instrumental to Vireo's success as one of the first multi-state operators in the United States, and his contributions to the Company through a rapidly evolving legislative and business landscape have been critical to our success. We thank him for those efforts and wish him the best in his future endeavors."
About Vireo Health International, Inc.
Vireo Health International, Inc. ("Vireo" or the "Company") is a physician-led cannabis company focused on bringing the best of technology, science, and engineering to the cannabis industry. Vireo manufactures proprietary, branded cannabis products in environmentally-friendly, state-of-the-art greenhouses and distributes its products through its growing network of Green GoodsTM retail dispensaries and through hundreds of third-party dispensaries in seven states. Vireo's team of more than 300 employees, led by scientists, engineers, and cultivation experts, is focused on efficiency and the creation of best-in-class products, while driving scientific innovation within the cannabis industry and developing meaningful intellectual property. Today, Vireo is licensed to grow and/or process cannabis in eight markets. The Company is operational in seven of those eight markets – including the core markets of Arizona, Maryland, Minnesota, New Mexico, New York, Pennsylvania. The Company holds 32 total retail dispensary licenses, of which 13 are currently open for business. For more information about Vireo Health, please visit www.vireohealth.com.
Media Inquiries
Albe Zakes
Vice President, Corporate Communications
albezakes@vireohealth.com
(267) 221-4800
Investor Inquiries
Sam Gibbons
Vice President, Investor Relations
samgibbons@vireohealth.com
(612) 314-8995
View original content to download multimedia:http://www.prnewswire.com/news-releases/vireo-health-provides-corporate-governance-update-301146010.html
SOURCE Vireo Health International, Inc.
FAQ
What recent corporate governance update has Vireo Health announced?
What positions did Ari Hoffnung hold at Vireo Health?
What does Vireo Health do in the cannabis market?
In how many states is Vireo Health operational?
What is the significance of Ari Hoffnung's resignation for Vireo Health?
